Kestra Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.74M | Sell |
126,696
-29,834
| -19% | -$2.06M | 0.04% | 421 |
|
|
2025
Q1 | $10.9M | Buy |
156,530
+17,562
| +13% | +$1.22M | 0.05% | 326 |
|
|
2024
Q4 | $12M | Buy |
138,968
+13,739
| +11% | +$1.18M | 0.07% | 307 |
|
|
2024
Q3 | $14.9M | Sell |
125,229
-19,866
| -14% | -$2.37M | 0.08% | 260 |
|
|
2024
Q2 | $19.3M | Buy |
145,095
+20,479
| +16% | +$2.72M | 0.11% | 202 |
|
|
2024
Q1 | $16M | Buy |
124,616
+23,641
| +23% | +$3.04M | 0.11% | 190 |
|
|
2023
Q4 | $10.4M | Buy |
100,975
+20,792
| +26% | +$2.15M | 0.08% | 262 |
|
|
2023
Q3 | $7.29M | Buy |
80,183
+29,823
| +59% | +$2.71M | 0.07% | 292 |
|
|
2023
Q2 | $4.07M | Buy |
50,360
+4,132
| +9% | +$334K | 0.04% | 433 |
|
|
2023
Q1 | $3.68M | Sell |
46,228
-49,230
| -52% | -$3.92M | 0.04% | 445 |
|
|
2022
Q4 | $6.46M | Buy |
95,458
+10,478
| +12% | +$709K | 0.06% | 347 |
|
|
2022
Q3 | $4.23M | Buy |
84,980
+5,656
| +7% | +$282K | 0.05% | 418 |
|
|
2022
Q2 | $4.42M | Buy |
79,324
+35,124
| +79% | +$1.96M | 0.05% | 392 |
|
|
2022
Q1 | $2.45M | Buy |
44,200
+6,278
| +17% | +$349K | 0.03% | 604 |
|
|
2021
Q4 | $2.12M | Sell |
37,922
-7,674
| -17% | -$430K | 0.02% | 655 |
|
|
2021
Q3 | $2.19M | Buy |
45,596
+6,550
| +17% | +$314K | 0.02% | 669 |
|
|
2021
Q2 | $1.64M | Buy |
39,046
+278
| +0.7% | +$11.6K | 0.02% | 729 |
|
|
2021
Q1 | $1.31M | Buy |
38,768
+16,706
| +76% | +$563K | 0.02% | 762 |
|
|
2020
Q4 | $774K | Buy |
22,062
+21,900
| +13,519% | +$768K | 0.01% | 989 |
|
|
2020
Q3 | $372K | Buy |
+162
| New | +$372K | 0.01% | 1007 |
|